Yuxin Du
Dalian Ocean University(CN)China Pharmaceutical University(CN)Okayama University(JP)Xizang Minzu University(CN)Xuzhou Medical College(CN)Fudan University(CN)National Health and Family Planning Commission(CN)Wuhan University(CN)Mudanjiang Medical University(CN)Kanion Pharmaceutical (China)(CN)LC Resources (United States)(US)Second People’s Hospital of Huai’an(CN)Zhongshan Hospital(CN)Jiangsu Cancer Hospital(CN)Renmin Hospital of Wuhan University(CN)Guangdong Baiyun University(CN)Health & Life (Taiwan)(TW)Jining Medical University(CN)China Agricultural University(CN)L-3 Communications (United States)(US)Zhejiang University of Technology(CN)Beihang University(CN)Nanjing Medical University(CN)
Publications by Year
Research Areas
Mathematical Biology Tumor Growth, Bioinformatics and Genomic Networks, RNA modifications and cancer, Retinal Development and Disorders, Cancer-related gene regulation
Most-Cited Works
- → Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity(2022)222 cited
- → Bioinformatics Approaches for Anti-cancer Drug Discovery(2019)143 cited
- → Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma(2022)131 cited
- → A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9)(2022)124 cited
- → Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed/refractory acute myeloid leukemia(2022)92 cited
- → Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets(2021)78 cited